|
|
Volumn 55, Issue 9, 2012, Pages 2547-2548
|
|
Renoprotective effects of renin-angiotensin-aldosterone system blockers in type 2 diabetes: Demystifying multiple treatment comparisons in a network meta-analysis
a,b,c
|
|
Author keywords
Angiotensin II receptor blockers; Angiotensin converting enzyme inhibitors; End stage renal disease; Multiple treatment comparisons; Nephropathy; Network meta analysis; Reno protective effect; Type 2 diabetes
|
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
IRBESARTAN;
LISINOPRIL;
LOSARTAN;
NIFEDIPINE;
NITRENDIPINE;
OLMESARTAN;
PLACEBO;
RAMIPRIL;
VALSARTAN;
VERAPAMIL;
CLINICAL PRACTICE;
DIABETIC PATIENT;
DRUG EFFICACY;
HUMAN;
KIDNEY FAILURE;
LETTER;
MEDICAL DECISION MAKING;
META ANALYSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
RENAL PROTECTION;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
ANGIOTENSIN RECEPTOR ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
HUMANS;
HYPERTENSION;
RENIN-ANGIOTENSIN SYSTEM;
|
|
EID: 84866124722
PISSN: 0012186X
EISSN: 14320428
Source Type: Journal
DOI: 10.1007/s00125-012-2619-9 Document Type: Letter |
|
Times cited : (3)
|
|
References (4)
|
